West Paces Advisors’s ResMed RMD Stock Holding History

West Paces Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53K	Buy	+13	New	+$2.69K	﹤0.01%	556
2025 Q2	–	Sell	-2	Closed	-$448	–	487
2025 Q1	$448	Hold	2	–	–	﹤0.01%	536
2024 Q4	$457	Hold	2	–	–	﹤0.01%	526
2024 Q3	$488	Hold	2	–	–	﹤0.01%	516
2024 Q2	$383	Hold	2	–	–	﹤0.01%	539
2024 Q1	$396	Sell	2 -4	-67%	-$733	﹤0.01%	555
2023 Q4	$1.03K	Buy	+6	New	+$922	﹤0.01%	505
2023 Q3	–	Sell	-4	Closed	-$874	–	554
2023 Q2	$874	Hold	4	–	–	﹤0.01%	498
2023 Q1	$876	Buy	4 +1	+33%	+$217	﹤0.01%	517
2022 Q4	$624	Sell	3 -4	-57%	-$879	﹤0.01%	496
2022 Q3	$1.53K	Hold	7	–	–	﹤0.01%	446
2022 Q2	$1.47K	Buy	7 +3	+75%	+$639	﹤0.01%	502
2022 Q1	$970	Buy	+4	New	+$968	﹤0.01%	531
2021 Q3	–	Sell	-108	Closed	-$26.6K	–	628
2021 Q2	$26.6K	Sell	108 -112	-51%	-$23.5K	0.01%	260
2021 Q1	$42.7K	Buy	+220	New	+$44.1K	0.02%	205

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

West Paces Advisors's RMD Position: Q2 2026 in Review

West Paces Advisors opened a new position in ResMed (RMD) in Q2 2026: 13 shares worth $2.53K. The stake represents ﹤0.01% of the portfolio and ranks #556 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in RMD as recently as Q1 2025.

West Paces Advisors first reported a position in RMD in Q1 2021 and has held it in 15 quarters since. The position peaked at $42.7K in Q1 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

West Paces Advisors held 13 shares of ResMed worth $2.53K as of Q2 2026.
ResMed was a new West Paces Advisors position in Q2 2026.
ResMed made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #556 holding.
West Paces Advisors first reported a position in ResMed in Q1 2021 and has held it in 15 quarters since.
West Paces Advisors's ResMed position peaked at $42.7K in Q1 2021.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.